申请人:IDORSIA PHARMACEUTICALS LTD
公开号:US10065929B2
公开(公告)日:2018-09-04
The invention relates to compounds of formula (I)
wherein X, Y, R1, R2, (R4)n, and (R5)m are as defined in the description, and to pharmaceutically acceptable salts of such compounds. These compounds are useful as calcium T-channel blockers.
本发明涉及式 (I) 的化合物
其中X、Y、R1、R2、(R4)n和(R5)m如描述中所定义,并涉及此类化合物的药学上可接受的盐。这些化合物可用作钙 T 通道阻滞剂。